FIERCELY FOCUSED
ON PATIENTS

Our Story

TG Therapeutics was founded with one goal in mind—to leverage scientific advances in B-cell biology to develop novel treatments for patients. 

We’ve dedicated ourselves to this simple concept and to the study of B-cells and B-cell diseases. To achieve our goal, we search the globe looking for medicines in early research that we believe could become valuable treatment options for patients.

Join Us
TG Therapeutics logo
X-twitter Linkedin
footer-hex
Scroll to Top
Important Safety Information
CONTRAINDICATIONS: BRIUMVI is contraindicated in patients with:
  • Active HBV infection
  • A history of life-threatening infusion reaction to BRIUMVI
 		Indication
BRIUMVI is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Click or scroll to see IMPORTANT SAFETY INFORMATION AND INDICATION

Important Safety Information
CONTRAINDICATIONS: BRIUMVI is contraindicated in patients with:
  • Active HBV infection
  • A history of life-threatening infusion reaction to BRIUMVI